Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer
Provided By GlobeNewswire
Last update: Feb 24, 2025
WELLESLEY HILLS, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) announced today the appointment of Perrin Wilson, Ph.D. as Chief Business Officer. Dr. Wilson is an accomplished leader, with over 17 years of experience in the pharmaceutical and biotech industry.
Read more at globenewswire.com1.23
-0.03 (-2.38%)
Find more stocks in the Stock Screener
CLYM Latest News and Analysis
11 days ago - ChartmillFriday's after hours session: top gainers and losersDiscover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.
